Top companies

ASIANPAINT - 2459.9 (0.53%) AXISBANK - 1160.3 (-0.9%) BAJAJFINSV - 2072.1 (-0.59%) BAJFINANCE - 1029 (0.34%) BHARTIARTL - 1929.1 (-0.5%) BPCL - 330.1 (-0.09%) COALINDIA - 393.4 (-0.17%) HDFCBANK - 948.6 (-0.9%) HEROMOTOCO - 5275 (-1.78%) HINDUNILVR - 2556.9 (1.38%) ICICIBANK - 1380.8 (-0.97%) INDUSINDBK - 741.6 (-1.81%) ITC - 401.3 (-0.47%) KOTAKBANK - 2031.8 (-0.78%) MARUTI - 16232 (0.84%) ONGC - 239 (0.99%) RELIANCE - 1385.8 (-0.29%) SBIN - 866.6 (-0.46%) TATAMOTORS - 683.05 (-2.61%) TATASTEEL - 172.94 (-0.2%) TCS - 3041.4 (-0.69%) TITAN - 3422.7 (-0.48%) WIPRO - 244.71 (-1.97%)
TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

Hold Ipca Laboratories, target price Rs 2240: Emkay Global

14 Dec , 2021   By : monika singh


Hold Ipca Laboratories, target price Rs 2240: Emkay Global

Emkay Global has hold call on Ipca Laboratories Ltd. with a target price of Rs 2240. The current market price of Ipca Laboratories Ltd. is Rs 2025.05.

Time period given by analyst is one year when Ipca Laboratories Ltd. price can reach defined target.

Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 25653.30 Crore) operating in Pharmaceuticals sector.
Ipca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives and Sale of services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 1562.51 Crore, down -1.53 % from last quarter Total Income of Rs 1586.81 Crore and up 13.51 % from last year same quarter Total Income of Rs 1376.55 Crore. Company reported net profit after tax of Rs 257.73 Crore in latest quarter.


0 Comment


LEAVE A COMMENT


Growmudra © 2026 all right reserved

Partner With Us